Batu Biologics Chief Executive Officer Samuel Wagner to Moderate Congressional Immunotherapy Symposium – Business Wire (press release)
Business Wire (press release) |
Batu Biologics Chief Executive Officer Samuel Wagner to Moderate Congressional Immunotherapy Symposium
Business Wire (press release) Batu Biologics has recently received FDA clearance to begin clinical trials using ValloVax, a type of immunotherapy that selectively kills blood vessels that feed cancer cells. This approach is anticipated to be more effective than other immune … |
